FAAH/MAGL-IN-2 is a potent, reversible, orally active, and blood-brain barrier permeable dual inhibitor of FAAH and MAGL (IC50 = 11 nM and 36 nM, respectively; Ki = 28 nM and 60 nM, respectively), with potential for the study of neuropathic pain without causing motor impairment.